<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00281476</url>
  </required_header>
  <id_info>
    <org_study_id>2005-004933-16</org_study_id>
    <nct_id>NCT00281476</nct_id>
  </id_info>
  <brief_title>The Effect of High Dose Simvastatine on Multiple Myeloma</brief_title>
  <official_title>The Effect of High Dose Simvastatine on Multiple Myeloma</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Vejle Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Vejle Hospital</source>
  <brief_summary>
    <textblock>
      The purpose of the study is to evaluate the effect of high doses of Simvastatine on bone
      metabolisme and biochemical markers of disease in Multiple Myeloma
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>February 2006</start_date>
  <completion_date type="Actual">November 2007</completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Response estimated by internationally approved criteria after 8 weeks of intermittend treatment with simvastatine</measure>
    <time_frame>8 weeks after treatment start</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Changes in markers of bone metabolisme after 8 weeks of intermittend treatment with simvastatine</measure>
    <time_frame>8 weeks after start of treatment</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Toxicity according to CTC after 8 weeks of intermittend treatment with simvastatine</measure>
    <time_frame>8 weeks after start of treatment</time_frame>
  </secondary_outcome>
  <enrollment type="Anticipated">10</enrollment>
  <condition>Multiple Myeloma</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Simvastatine</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  multiple myeloma-patients in need of treatment

          -  stable og progressive disease

          -  age = or &gt; 18 years

          -  performance status &lt; 3

          -  life expectancy &gt; 3 months

        Exclusion Criteria:

          -  pregnancy

          -  patients incapable of giving personally concent

          -  renal insufficiens with creatinine clearance below 25 ml/min

          -  alanin aminotransferasis &gt; 2,5 x upper reference limit

          -  thyroxine below lower reference limit

          -  known familiar muscle-disease ar previous myopati

          -  creatinine kinase &gt; 10 x upper reference limit

          -  medication with drugs with known interactions wiht simvastatine
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Torben Plesner, DMSc.</last_name>
    <role>Principal Investigator</role>
  </overall_official>
  <verification_date>October 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 23, 2006</study_first_submitted>
  <study_first_submitted_qc>January 23, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 24, 2006</study_first_posted>
  <last_update_submitted>October 31, 2011</last_update_submitted>
  <last_update_submitted_qc>October 31, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 1, 2011</last_update_posted>
  <keyword>multiple myeloma</keyword>
  <keyword>statins</keyword>
  <keyword>bone</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Multiple Myeloma</mesh_term>
    <mesh_term>Neoplasms, Plasma Cell</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Simvastatin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

